We show that the Nuclear factor erythroid 2-related factor 2 (NRF2) antioxidant response pathway is activated in HLRCC ULMs and that multiple NRF2 target genes are elevated at the protein level in these tumors. The gene discussed is NFE2L2; the disease is hereditary leiomyomatosis and renal cell cancer.